Tinnitus is a spontaneous, internally generated noise which is usually heard in one ear but can be heard in both ears. It is primarily a subjective complaint, and the severity is dependent primarily on the patient’s description. Almost any condition that causes malfunction of the auditory end-organ might cause tinnitus, but the most common cause is age degeneration (presbycusis). Other causes are biochemical changes, e.g., from aspirin, Meniere’s disease, trauma (acoustic or chemical), high levels of aspartate or glutamate and labyrinthitis. It may occur alone or in concert with other symptoms such as head, neck and back pain: dizziness (vertigo); otalgia; impaired hearing; stuffy sensations in the ears; double and blurred vision; various TM joint noises during chewing; maximum voluntary clenching; maximum jaw protrusion; mouth opening against resistance; and pressure applied to the ipsilateral temporomandibular joint.
Tinnitus is a degenerative neurological condition that is affected by excitotoxins. Dr. Russell Blaylock, MD, professor of neurosurgery at the University of Mississippi (author of the book “Excitotoxins: The Taste That Kills”) makes a compelling case indicating that high levels of “aspartate or glutamate in the brain kills neurons by allowing the influx of too much calcium into the cells. This influx triggers excessive amounts of free radicals which kills the cells. The neural cell damage that can be caused by these compounds is why they are referred to as “excitotoxins.” They excite or stimulate the neural cells to death”. (To read more: https://www.tinnitusformula.com/library/neurotoxins-and-tinnitus-aspartame-msg-solutions/).
Tinnitus is present in approximately one-third of patients who present with ear pain, fullness, hearing loss, etc. The patient may also complain of high hissing sound, not the roaring type. In older patients exhibiting a high frquency sensorineural hearing loss, tinnitus could be attributed to a degenerative process in the cochlea of the ear.
Patients with temporomandibular disorders report a higher prevalence of tinnitus than do age matched control groups. Also TMD has been implicated as a cause of tinnitus. As many as one-third (32%) of all Americans experience tinnitus sometimes in their lives. These data are supported sometime in their lives. These data are supported by similar studies performed in Europe. It is estimated that approximately 18 million Americans seek medical attention for their tinnitus. Nine million report being seriously affected by their condition, and two million are disabled because of elusive sounds.
There are two historical classifications for tinnitus.
- Objective tinnitus refers to a noise that can be heard by both the patient and physician. This formation of tinnitus is usually derived from one of two sources: the vascular system or from the muscle contraction.
- Vascular tinnitus is usually pulsatile and synchronous with the pulse. Glomus tumors, aneurysms along the carotid system, and other vascular malformations cause a pulsatile tinnitus that can be heard with a stethoscope and that abates when pressure is applied to the feeding vessels. The tinnitus of muscle contraction is usually a most annoying ringing sound caused by clonic activity of the tensor veli palatini (palatal myoclonus).
Neurotoxins and Tinnitus: Aspartame and MSG Connection
Both aspartame and monosodium glutamate (MSG) are excitatory neurotransmitters found as food additives such as: NutraSweet, Equal, Spoonful, Indulge and Equal-Measure to name a few. MSG is a flavor enhancer used in many processed and prepackaged foods. MSG breaks down into glutamate in the body. Glutamate, like aspartate, is an excitatory neuro-transmitter; it triggers the firing of neurons. When there is too much glutamate in the synapse between neurons, it activates the neurons into a continual firing mode until they exhaust their energy reserves and die.
These excitatory neurtransmitters effect the brain neurons and increase levels of electrical activity in the brain and the auditory cortex, the area where tinnitus is perceived. It has been recognized that people with tinnitus have an elevated level of electrical activity. Reducing this activity is helpful for tinnitus. Increasing electrical activity increases tinnitus. For this reason many researchers refer to these excitatory neurotransmitters as excitotoxins.
By the FDA’s own admission, 73 percent of all food complaints are aspartame related. A few of the 90 different documented symptoms listed in the FDA Adverse Reaction Monitoring System include: headache/migraine, memory loss, hearing loss, tinnitus, vertigo, seizures, nausea, depression, heart palpitations, vision problems, fatigue, irritability, muscle spasms, weight gain, anxiety attacks, insomnia, heart palpitations, breathing difficulties and joint pain.
In addition, there is a wealth of documented evidence that suggests aspartame can trigger or worsen the following chronic neurological illnesses: brain tumors, multiple sclerosis, epilepsy, chronic fatigue syndrome, Parkinson’s disease, Alzheimer’s disease, mental retardation, lymphoma, birth defects, Fibromyalgia, hypoglycemia and diabetes.
Treatment has been frustrating for the treating physician who often prescribes tranquilizers and muscle relaxants in an effort to control muscle contraction. Although there is no specific medical or surgical therapy for tinnitus, many patients find relief by playing background music to mask the tinnitus. A hearing aid for the associated hearing loss often results in suppression of the tinnitus. Some patients benefit from use of a tinnitus masker, a device worn like a hearing aid that presents a noise more pleasant than tinnitus.
“Ginkgo biloba and zinc, found in Arches Tinnitus Formula, are both antioxidants. Ginkgo biloba is also a powerful neuro-protector and helps to mitigate some of the damage done by excitotoxins. Numerous clinical studies have demonstrated ginkgo biloba’s ability to protect neuronal systems in the brain.”
Current Medical Theory
Current medical theory is that the majority of cases of tinnitus have no detectable acoustic basis, but instead arise from anomalies in one or more of the elements of the neural chain that constitutes the auditory nervous system. In the past few years, experts treating patients from a stomatognathic approach have had success in alleviating tinnitus. However, since tinnitus can be a symptom of serious ear disease, it is recommended that an ENT or neurological evaluation be performed prior to initiating dental treatment.
For more than half a century, investigators have attempted to explain the association between TMJ and tinnitus in the dental otologic literature. One of the first was Costen, who speculated that pressure from the condyle could cause eustachian tube blockage, thereby producing tinnnitus. A second hypothesis, which is implicated with eustachian tube, was based on the common nerve supply to the masticatory muscles and tensor veli palatini muscle. These researchers speculated that hyperactivity of the masticatory muscles could induce a secondary reflex contraction of the tensor veli palatini muscle, congestion of the middle ear, and consequently tinnitus.
Others have proposed the concept that the middle and inner ears receive input from the trigeminal nerve and sympathetic nerves of the middle ear through the tympanic plexus, thus speculating these combined inputs might be responsible for tinnitus. Chan and Read speculated that a masseter muscle trigger point may cause tinnitus and referred pain at distant locations. Other investigators speculated that inflammation within the TMJ could be a source of tinnitus.
It has been reported that palpation of the deep masseter, medial pterygoid, lateral pterygoid, and sternocleidomastoid muscles can reproduce or intensify a patient’s tinnitus.
After proper dental therapy tinnitus, has been known to generally relieve. It has been reported that TMD therapy improves tinnitus in 46-96% of patients who have TMD and coexisting tinnitus. The neuromuscular dentist has the ability to measure masticatory muscle activity at rest and in function, thereby obtaining quantitative objective data from which therapy can be instituted. It has been the author’s clinical experience that when masticatory and associated muscle activity are optimally at rest and in function, TMD complaints of tinnitus usually resolves. When the only complain is tinnitus with no TMD complaints, resolution of tinnitus is usually limited/poor.
Which TMD patients have the greatest likelihood of experiencing tinnitus improvement?
- The age range is 18-76 years.
- Occurs less frequently on a monthly basis rather than on a constant basis.
- Lasts for a short period of time, seconds rather than continuous.
- Hearing is normal.
- They have pain in their ipsilateral ear.
- Tinnitus began approximately when TMD symtptoms began.
- More intense when the TMD symptoms increase.
- Appears to be related to stress.
- They experience changes in tinnitus (such as intensity) when they move their jaw.
- Tinnitus is reproduced or intensified when thy clench their posterior teeth as hard as possible.
It is unfortunate that the medical and dental profession has a very limited knowledge or understanding in the arena of gneuromuscular (GNM) craniomandibular orthopedics. Literature is sparse and most health care providers have little to no understanding of the necessity for a multidisciplinary approach to the treatment of patients suffering from eustachian tube dysfunction, otalgia, and/or tinnitus.
After medical treatment options have been exhausted, it is essential that gneuromuscular (GNM craniomandibular) orthopedics be considered.
- Karmody C: Otolaryngology. Philadelphia: Lead & Febiger, 1989;149-160.
- Jafek BW: ENT Secrets. Philadelphia: Hanley & Belfus; 1996;58.
- Lucente, F: The Merck Manual, 16th Ed. 1992;2324-2325.
- Dovok, E: Classification of tinnitus. In CIBA Foundation Symposium. London: Pitman Press, 1991.
- Rubenstein B: Tinnitus and craniomandibular disorders – Is there a link? Swed Dent J Supply 1993;95;1-46.
- Chole KA, Parker WS: Tinnitus and vertigo in patients with temporomandibular disorders. Arch Otolargyngol Head Neck Surg 1992:118(8);817-821.
- Ash CM, Pinto OF: the TMJ and the middle ear; structural and functional correlates for aural symptoms associated with temporomandibular joint dysfunction. Int J Prosthodont 1991:4(1):51-57.
- Chan SW, REade P: Tinnitus and temporomandibular pain dysfunction disorders. Clin Orolaryngoly 1994:19;370-80.
- Meyerhoff WL, Cooper JF, Paderella MM, Shumarisk DA, Gluckman IL: Tinnitus in Orolaryngology 3rd ed. Philadelphia: W. B. Saunders Co.; 1991; 1169-79.
- Myers LJ: Possible inflammatory pathways relating temporomandibular joint dysfunction to otic symptoms. J Craniomandib Pract 1998;6:64-70.
- Alkofide EA, Clark E., Bermani W, Kronman JH, Mehta H: The incidence and nature of fibrous continuity between the sphenomandibular ligament and the anterior malleolar ligament of the middle ear. J Orofacial Pain 1997;4;7-14.
- Eckemal O: The petrotympanic fissure: A link connecting the tympanic cavity and the temporomandibular joint. J Craniomandibl Pract 1991;9(1):15-22.
- Pinto OF: New structure related to the temporomandibular joint and the middle ear. J Prosthet Dent 1962;12(1);95-103.
- Arlen, H: The otomandibular syndrome. In: Gelb H, ed. Clinical Management of Head, Neck and TMJ Pain and Dysfunction. Philadelphia: W. B. Saunders Co.;1985;181-185.
- Bush FM: Tinnitus and otalgia in temporomandibular disorders. J Prosthet Dent 1987: 58(4):495-498.
- Bernstein JM, Mohl ND, Spiller H: Temporomandibular joint dysfunction masquerading as disease of the ear, nose and throat. Trans Am Acad Opthalmol Otolargyngol 1969;73(6):1208-1217
- National Institutes of Health Technology Assessment Conference Statement. Management of Temporomandibular Disorders. J Am Dent Assoc 1996;127:1595-1606.